Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Conditions: Follicular Lymphoma; Marginal Zone Lymphoma; B-Cell Lymphoma Interventions: Drug: Zanubrutinib; Drug: Rituximab Sponsors: H. Lee Moffitt Cancer Center and Research Institute; BeiGene, Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials